Patent · US Active

Compound and use thereof and platinum complex and lipidosome thereof

US10730898B2 · kind B2 · utility

0Cited by
3References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 13, 2017
Grant dateAug 4, 2020
Priority date
Expiry dateJan 13, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are a platinum complex and a liposome thereof, and a use thereof. The platinum complex contains a carboxyl group having pH sensitivity, wherein in a comparatively low pH environment (such as in tumour tissues), the carboxyl group is liable to deprotonate, facilitating an improvement in the drug release inside tumour tissues and improving the therapeutic effect of drugs. In addition, the platinum complex can be well combined with the membrane materials of lipidosomes, so as to improve the encapsulation ratio and drug loading capacity of lipidosomes. Experiments indicate that the lipidosomes of the platinum complex can reduce the toxic and side effects of drugs and increase the therapeutic effect thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.